A double-blind, placebo-controlled, dose-escalation trial of pimavanserin in Parkinson's disease and psychosis

被引:0
|
作者
Revell, Stephen
Friedman, Joseph
Mills, Roger G.
Williams, Hilde
Johnson, Ann D.
Bahr, Daun
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A284 / A285
页数:2
相关论文
共 50 条
  • [31] Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in PD
    Friedman, J.
    Ravina, B.
    Mills, R.
    Williams, H.
    Bahr, D.
    Peters, P.
    Tison, F.
    Burn, D.
    MOVEMENT DISORDERS, 2010, 25 : S674 - S674
  • [32] Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial
    Brodaty, H
    Ames, D
    Snowdon, J
    Woodward, M
    Kirwan, J
    Clarnette, R
    Lee, E
    Greenspan, A
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 20 (12) : 1153 - 1157
  • [33] Repifermin (keratinocyte growth factor 2) for the treatment of active ulcerative colitis: A randomized, double-blind, placebo-controlled, dose-escalation trial
    Sandborn, WJ
    Sands, BE
    Wolf, DC
    Valentine, J
    Safdi, M
    Katz, S
    Isaacs, KL
    Wruble, LD
    Katz, JA
    Present, DH
    Loftus, EV
    Odenheimer, DJ
    Hanauer, SB
    GASTROENTEROLOGY, 2002, 122 (04) : A61 - A61
  • [34] Treatment of Common Cold Patients with the Shi-Cha Capsule: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Trial
    Chang, Jing
    Dong, Shou-Jin
    She, Bin
    Zhang, Rui-Ming
    Meng, Mao-Bin
    Xu, Yan-Ling
    Wan, Li-Ling
    Shi, Ke-Hua
    Pan, Jun-Hun
    Mao, Bing
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [35] Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease
    Suzuki, Masahiko
    Yoshioka, Masayuki
    Hashimoto, Masaya
    Murakami, Maiko
    Noya, Miki
    Takahashi, Daisuke
    Urashima, Mitsuyoshi
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2013, 97 (05): : 1004 - 1013
  • [36] Zishenpingchan granules for the treatment of Parkinson's disease:a randomized,double-blind,placebo-controlled clinical trial
    Qing Ye
    Xiao-Lei Yuan
    Can-Xing Yuan
    Hong-Zhi Zhang
    Xu-Ming Yang
    Neural Regeneration Research, 2018, (07) : 1269 - 1275
  • [37] Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
    Asako Yoritaka
    Yasuko Kobayashi
    Tetsuo Hayashi
    Shinji Saiki
    Nobutaka Hattori
    Neurological Sciences, 2021, 42 : 4767 - 4770
  • [38] Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson's disease: a pilot study
    Yoritaka, Asako
    Kobayashi, Yasuko
    Hayashi, Tetsuo
    Saiki, Shinji
    Hattori, Nobutaka
    NEUROLOGICAL SCIENCES, 2021, 42 (11) : 4767 - 4770
  • [39] Zishenpingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial
    Ye, Qing
    Yuan, Xiao-Lei
    Yuan, Can-Xing
    Zhang, Hong-Zhi
    Yang, Xu-Ming
    NEURAL REGENERATION RESEARCH, 2018, 13 (07) : 1269 - 1275
  • [40] Pingchan granule for depressive symptoms in parkinson's disease: A randomized, double-blind, placebo-controlled trial
    Gu, Si-chun
    Zhou, Jie
    Ye, Qing
    Yuan, Can-xing
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (02): : 120 - 128